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Isolated chloroplast coupling factor (CF,), when depleted of its s-subunit, has a high ATPase activity which can be inhi- 
bited by binding E to a single high-affinity (& = 1.4x 1O-io M) site. In CF, reduced by dithiothreitol (DTT), however, 
E at this binding site is no longer inhibitory. Instead, 3 equivalent, lower affinity (& =6 x 10-s M), inhibitory binding 
sites for E are observed, whether or not the high-affinity site contains a bound s-subunit. Binding of E to the high-affinity 
site protects CF, against trypsin activation, while binding to the low-affinity site does not, showing that occupation of 
each class of site has a different effect on CF, structure. The effects of DTT can be interpreted in terms of a reduction 
in intersubunit cooperativity in CF,. 
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1. INTRODUCTION 
The ATP synthase of chloroplasts (CFr-CFo) 
couples the dissipation of a light-induced pH gra- 
dient to the phosphorylation of ADP. It also 
possesses a latent ATPase activity, which is reveal- 
ed after treatment with dithiols or trypsin. The 
nucleotide binding and catalytic sites of this com- 
plex reside on the two largest subunits of CFr 
(designated cy, ,& for a review see [l]). However, 
two other subunits of CFr, the y- and c-subunits, 
are implicated in regulation of its ATPase activity 
[2-41. 
In membrane-bound CFi, ATPase activation 
can be correlated with the reduction of a 
disulphide bridge (using DTT) within the y-subunit 
[5] or by cleavage of this subunit by trypsin [6]. 
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Reduction of the y-subunit of isolated CFi also in- 
creases its ATPase activity [7]. However, the E- 
subunit has also been implicated in the activation 
of isolated CFi. Thus, removal of the f-subunit (by 
ion-exchange chromatography) increases ATPase 
activity, while rebinding leads to inhibition [3,4], 
which is complete at a 1: 1 molar ratio [8]. The 
relationship between DTT activation and 6 
removal, has, however, remained unclear. 
We show here that DTT activation of CFr does 
not remove its intrinsic e-subunit, but masks its in- 
hibitory properties. Further, DTT activated CFr 
can be inhibited by added 6; this binds not to the 
binding site of the intrinsic E but to 3 lower affinity 
binding sites on CFi, which may well lie on the 
three (catalytic) &subunits. 
2. MATERIALS AND METHODS 
CFi was prepared from fresh market spinach according to the 
method of Lien and Racker 191 and was frozen in liquid 
nitrogen and stored at -70°C or kept at 4°C as a precipitate 
in 2 M ammonium sulphate, pH 7.5. e and e-depleted CFi were 
prepared by the method of Richter et al. [8], except that DEAE- 
Sephacel was used in the place of DEAE-cellulose, and the e- 
elution buffer was 25 mM TEA-NaOH, pH 7.9, 2 mM ATP, 
20 mM NaCl, 20% ethanol (v/v) and 30% glycerol (v/v) (buf- 
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fer A). Eluted t was concentrated by ultrafiltration using an 
Amicon model 8010 with a YM5 membrane. 
DTT activation of CF, was by a modification of a published 
procedure [lo]. 0.4 ml of 20 mM tricine-NaOH, pH 8.0, 1 mM 
EDTA, 1 mM ATP and 50 mM DTT containing l-2 mg/ml 
CFr, was incubated for 3 h at room temperature. The samples 
were then diluted 5-fold with 20 mM tricine-NaOH, pH 8.0, 
1 mM EDTA and used immediately. (Further dilution of these 
samples in the various incubation media resulted in a final DTT 
concentration of less than 1 mM.) For the titrations, E was add- 
ed from a 0.1 mg/ml solution to 0.12 ml aliquots containing 
20 pg/ml CF,, 20 mM tricine-NaOH, pH 8.0, and 1 mM 
EDTA, and were mixed immediately. After 5 min at room 
temperature Ca-ATPase activity was assayed, by a published 
procedure [9]. 
Trypsin activation of CFr was modified from [8]. To 0.75 ml 
of a solution containing 40gg/ml coupling factor, 20 mM 
tricine-NaOH, pH 8.0, and 1 mM EDTA, was added 0.24 ml of 
either 0.102 mg/ml purified 6, or buffer A alone. Where in- 
dicated, samples were then reoxidised by a 10 min incubation 
with 2 mM o-iodosobenzoate (IBZ). Digestion was initiated us- 
ing 10 pl of 0.1 mg/ml TPCK-trypsin in 2 mM HCI. 80 pl ali- 
quots were withdrawn and quenched at the indicated times by 
addition to 40 ~1 of 0.1 mg/ml soybean trypsin inhibitor, and 
Ca-ATPase activity determined. 
The concentration of e was determined using fluorescamine 
[I l] with bovine serum albumin as protein standard. Unbound 
6 was effectively removed from solution by centrifugation 
through a Sephadex G-75 column (0.75 cm x 6 cm) 
equilibrated with 25 mM TEA-NaOH, pH 7.9, 1 mM ATP, 
1 mM EDTA, as described by Penefsky [12]. Coupling factor 
subunits were identified by SDS-polyacrylamide gel elec- 
trophoresis (SDS-PAGE) using an 8-12% linear acrylamide 
gradient and the discontinuous buffer system of Laemmli [13], 
and were stained by the method of Morrissey [14]. A molecular 
mass of 14700 Da was used fore [15], of 400 kDa for CF, [16] 
and of 385 300 Da for E-depleted CFr. DTT, TPCK-trypsin and 
soybean trypsin inhibitor were supplied by Sigma (England), 
and all reagents were of analytical grade. 
3. RESULTS 
Both E depletion of CFr and DTT treatment in- 
crease the ATPase activity of our CFr preparation 
(fig.1). However, DTT treatment does not result in 
the loss of the e-subunit from CFr. DTT activa- 
tion, followed by centrifugation through a column 
of Sephadex G-75, results in a CFr preparation 
containing as much c-subunit as native CFr (fig.1, 
tracks 3 and 4). Tracks 1 and 2 show that free E 
itself is adsorbed in the column. Control ex- 
periments (not shown) indicate that E is also retain- 
ed by the column in the presence of either albumin 
or beef heart Fr-proteins which show no specific 
interaction with E. Thus, DTT activation cannot 
involve freeing the f-subunit from CFr. 
In spite of the endogenous E in DTT activated 
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Sample : E 
ATPase : - - 0.7 6.6 9.6 
G-75 : - + - + - 
Fig.1. l content of activated CFr preparations. 4 pg of CFr, 
following: no pretreatment (norm), DTT treatment (DTT), or 
e removal ( - 6) or 0.2 yg of 6 were subjected to SDS-PAGE with 
(+) or without (-) prior passage through Sephadex G-75. 
Corresponding ATPase activities are expressed in pmol Pi 
released/min per mg protein. 
CFr, the preparation is still inhibited by added 6. 
This is demonstrated in fig.2, where E binding to 
various CFr preparations is measured. This figure 
also shows that the affinity of DTT activated CFr 
for E is considerably lower than that of e-depleted 
CFr. These data were analysed as in [15] (fig.2, in- 




where LO is the concentration of added E in the 
preincubation, EO the concentration of 6 binding 
sites and (Y the fractional saturation of CFr with 6 
(calculated on the assumption that E bound is 
directly proportional to the fall in ATPase activi- 
ty). Such treatment shows that he dissociation 
constant Kd (slope of line) increases from 1.4 x 
IO-” M (for E-depleted CFr) to 6 x lo-* M (for 
DTT activated CFr). In addition the number of 
binding sites (intercept) increases, from 1 .l to 
3.2 mol E/mol CFr. 
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Fig.2. Inhibition of ATPase activity of CFr preparations by 
as explained in text. 
purified e-subunit. (A) Native CFr, (0) e-depleted CFr. Open 
symbols before, closed symbols after, DTT treatment. ATPase 
activities at 100% were (A) 0.88; (0) 4.3; (A) 8.8; and (e) 
13.3 amol/min per mg. (Inset) Linearisation of the same data, 
This experiment was repeated with DTT ac- 
tivated CFi which had been f-depleted prior to 
DTT treatment. Surprisingly, E binding to this 
preparation followed a curve indistinguishable 
from that observed with the undepleted prepara- 
tion (fig.2, upper curves). Thus, besides revealing 
3 inhibitory, low-affinity binding sites for E on 
CFr, DTT treatment also prevents access of added 
6 to the preexisting E binding site even when this is 
empty. These effects of DTT are reversible: reox- 
idation of e-depleted, DTT-activated CFi with 
iodosobenzoate yields a preparation with a single, 
high-affinity, binding site for e as seen in CFr 
which has been simply depleted of its E-subunit 
(not shown). The additional observation (fig.2) 
that the relatively low ATPase activity of native 
CFr is also reduced by E addition, could possibly be 
attributed to a small proportion of the CFr sample 
which lacks E at its high-affinity site. 
There thus appear to be 2 classes of E binding site 
on CFi with very different affinities, which are 
non-overlapping (since e can bind to both 
simultaneously, at least on DTT-activated CFr). 
0 4 8 12 0 4 6 12 
Digestion time (min) 
Fig.3. Trypsin activation of CFr with E bound at either the high- 
or low-affinity binding sites. (A) e-depleted CFr; (B) native 
details, see section 2. 
CF,. Prior to trypsin treatment: (0) no further pretreatment; 
(0) addition of E; (A) DTT treatment; (A) DTT treatment 
followed by addition of E; and (+) DTT treatment, 6 addition, 
then reoxidation using iodosobenzoate (IBZ). For experimental 
Further evidence that these sites are discrete come 
from studies on activation of CFi by trypsin, 
which activates by cleavage at a site other than on 
the f-subunit [ 18,191. Despite having a high 
ATPase activity as compared to native CFi, both 
DTT-activated and c-depleted CFr can be further 
activated, about 2-fold, by a brief treatment with 
trypsin (fig.3). E can be bound to both these 
preparations but, as shown above, after DTT 
treatment only the low-affinity sites are filled. 
Rebinding of 6 to the high-affinity binding site 
considerably decreases the rate of activation of 
CFi by trypsin (fig.3A, cf. 0, 0). However, 6 
binding to the lower affinity sites in the DTT- 
treated preparations, while inhibiting ATP 
hydrolysis, yields no such protection and trypsin 
activation remains rapid (fig.3, cf. A , A ). It is 
concluded that E bound in native CFr protects a site 
susceptible to tryptic cleavage which affects CFr 
activity (as previously shown by Richter et al. [S]), 
while in DTT-treated CFr neither 6 at the induced 
low-affinity sites, nor at the modified preexisting 
site, protect from trypsin digestion. Again, 
405 
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iodosobenzoate reverses the effect of DTT (fig.3A, 
+ ) and isolated, untreated CFr shows some indica- 
tion that a small proportion of it lacks 6 at the 
high-affinity site (fig.3B, cf. 0, l ) as both the in- 
itial rate of ATP hydrolysis and its subsequent in- 
crease are diminished by 6 addition. 
4. DISCUSSION 
Trypsin treatment, reduction with DTT and 
removal of the f-subunit are all procedures which 
lead to an increased ATPase activity of isolated 
CFr. Their ultimate effects are presumably 
manifest on the catalytic @) subunit of this en- 
zyme, but their immediate effects are disparate. 
Trypsin activation seems to correlate with partial 
digestion of the CY- and y-subunits of soluble CFi 
[18], DTT activation with reduction of thiols on 
the y-subunit [7], and the f-subunit may interact 
with either the y-subunit [8] or directly with the ,& 
subunit of CFr [20]. 
CFr appears to have one tight and 3 weaker 
binding sites for E, all of which are inhibitory to 
ATPase activity by this enzyme (fig.2). The tight 
binding site has previously been reported by 
Richter et al. IS]. The weaker sites can be seen only 
after activation by DTT, though whether they are 
exposed by DTT, or always present (with their in- 
hibitory effect masked by the similar effect of the 
higher affinity site) is not clear from these data. 
The existence of 3 identical, low-affinity binding 
sites fore certainly suggests that these reside on the 
cy- or &subunits, the only subunits present in 
triplicate [16,20]. Indeed, E or its equivalent has 
been shown to interact with the P-subunit of Fi 
from E. cofi [21] or ox heart [22]. 
DTT appears to mask the effect of the intrinsic 
e subunit of CFr: after treatment, E bound at the 
high-affinity site no longer inhibits nor protects 
CFr from trypsin (fig.3). Further, the high-affinity 
site itself is masked: if emptied before DTT- 
treatment, the site cannot be filled unless the 
reduction is reversed. Such isolation of the high- 
affinity site may be accomplished by eliminating 
intersubunit cooperativity, allowing the 3 ,& 
subunits to function independently. 
To extrapolate these data to the situation in vivo 
is difficult. As the presence of 2 6 per CFr has been 
commonly reported [23-251 both the high- and 
low-affinity binding sites may be at least partially 
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occupied in native CFr . Whatever the 
stoichiometry in vivo, a means of regulation in- 
volving the alternation of 6 between the low- and 
high-affinity sites may be envisaged. Such an ex- 
change would require a change in the relative af- 
finities of the two types of binding site for 6. Of 
possible relevance is the increase in the accessibility 
of the c-subunit of thylakoid bound CFi to anti-6 
antibody during illumination, recently reported by 
Richter and McCarty [26]. Their further observa- 
tion that the antibody actually removed 6 from CFi 
under such conditions, might be explained by a 
concomitant reduction in affinity of CFi for 6 (i.e. 
a rise in &). It is therefore feasible that 6 displace- 
ment from a high- to a low-affinity binding site is 
involved in the activation process in vivo. 
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